Increased expression and no mutation of the flap endonuclease (fen1) gene in human lung cancer

Nature

Increased expression and no mutation of the flap endonuclease (fen1) gene in human lung cancer"


Play all audios:

Loading...

ABSTRACT The underlying molecular mechanisms leading to microsatellite alteration and mutations in human lung cancer remain unknown. Since _Flap endonuclease1_ (_Fen1_), which functions in


the base excision repair system, has been shown to be involved in tumor progression of mouse models with microsatellite instability in a haplo-insufficient manner, we performed expression


and mutation analyses for _FEN1_ in human lung cancer cell lines. Reverse transcriptase PCR analysis revealed that all 49 lung cancer cell lines (20 small cell lung cancers (SCLCs) and 29


non-small cell lung cancers (NSCLCs)) expressed _FEN1_. In addition, microarray analysis showed that _FEN1_ expression was elevated significantly by 1.65-fold (_P_=0.001) in SCLC cell lines


compared to normal lung controls (normal human lung cultures and immortalized normal human bronchial epithelial cell lines). FEN1 protein was abundantly expressed in all 23 lung cancer cell


lines (10 SCLCs and 13 NSCLCs) and was expressed at lower levels in three of four normal lung epithelial culture controls. Direct sequencing of genomic DNAs revealed no _FEN1_ mutation in


seven SCLCs and nine NSCLCs. As part of this analysis we discovered and sequenced a _FEN1_ pseudogene (GenBank accession #AY249897) located at 1p22.2. This pseudogene is amplified from cDNA


preparations contaminated with genomic DNA and must be taken into account in any _FEN1_ mutation analysis studies. Our results suggest that alterations of _FEN1_ are not likely to contribute


to development of lung cancer. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your


institution Subscribe to this journal Receive 50 print issues and online access $259.00 per year only $5.18 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access


to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our


FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS WHOLE‑EXOME SEQUENCING REVEALS LEWIS LUNG CARCINOMA IS A HYPERMUTATED _KRAS_/_NRAS_–MUTANT CANCER WITH EXTENSIVE


REGIONAL MUTATION CLUSTERS IN ITS GENOME Article Open access 02 January 2024 ΔNP63 REGULATES A COMMON LANDSCAPE OF ENHANCER ASSOCIATED GENES IN NON-SMALL CELL LUNG CANCER Article Open access


01 February 2022 INTEGRATIVE GENOMICS IDENTIFIES SHPRH AS A TUMOR SUPPRESSOR GENE IN LUNG ADENOCARCINOMA THAT REGULATES DNA DAMAGE RESPONSE Article Open access 18 June 2024 ABBREVIATIONS *


SCLC: small cell lung cancer * NSCLC: non-small cell lung cancer * HNPCC: hereditary nonpolyposis colon cancer * RT–PCR: reverse transcriptase PCR * MSI: microsatellite instability * MMR,


mismatch repair: BER, base excision repair REFERENCES * Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Peterson GM,


Kinzler KW, Vogelstein B and de la Chapelle A . (1993). _Science_, 260, 812–816. * Bambara RA, Murante RS and Henricksen LA . (1997). _J. Biol. Chem._, 272, 4647–4650. * Bhattacharyya N,


Chen HC, Comhair S, Erzurum SC and Banerjee S . (1999). _DNA Cell Biol._, 18, 549–554. * Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas


MA, Fodde R, Ranzani GN and Srivastava S . (1998). _Cancer Res._, 58, 5248–5257. * Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, Puisieux A and Frebourg T . (2002).


_Cancer Res._, 62, 848–853. * Chen KH, Yakes FM, Srivastava DK, Singhal RK, Sobol RW, Horton JK, Van Houten B and Wilson SH . (1998). _Nucleic Acids Res._, 26, 2001–2007. * Girard L,


Zochbauer-Muller S, Virmani AK, Gazdar AF and Minna JD . (2000). _Cancer Res._, 60, 4894–4906. * Guggenheimer RA, Nagata K, Kenny M and Hurwitz J . (1984). _J. Biol. Chem._, 259, 7815–7825.


* Harrington JJ and Lieber MR . (1994). _EMBO J._, 13, 1235–1246. * Harrington JJ and Lieber MR . (1995). _J. Biol. Chem._, 270, 4503–4508. * Hiraoka LR, Harrington JJ, Gerhard DS, Lieber MR


and Hsieh CL . (1995). _Genomics_, 25, 220–225. * Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M . (1993). _Nature_, 363, 558–561. * Kim K, Biade S and Matsumoto Y . (1998). _J.


Biol. Chem._, 273, 8842–8848. * Kucherlapati M, Yang K, Kuraguchi M, Zhao J, Lia M, Heyer J, Kane MF, Fan K, Russell R, Brown AM, Kneitz B, Edelmann W, Kolodner RD, Lipkin M and


Kucherlapati R . (2002). _Proc. Natl. Acad. Sci. USA_, 99, 9924–9929. * Lindahl T . (1971). _Eur. J. Biochem._, 18, 407–414. * Peltomaki P and Vasen HF . (1997). _Gastroenterology_, 113,


1146–1158. * Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD and Mulshine JL . (1996). _J. Cell. Biochem.


Suppl._, 24, 32–91. * Sekido Y, Fong KM and Minna JD . (2003). _Annu. Rev. Med._, 54, 73–87. * Siegal G, Turchi JJ, Myers TW and Bambara RA . (1992). _Proc. Natl. Acad. Sci. USA_, 89,


9377–9381. * Thibodeau SN, Bren G and Schaid D . (1993). _Science_, 260, 816–819. * Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM,


Burgart LJ, Honchel R and Halling KC . (1996). _Cancer Res._, 56, 4836–4840. * Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM,


Gilcrease M, Herman J, Minna JD and Gazdar AF . (2001). _Clin. Cancer Res._, 7, 1998–2004. * Waga S and Stillman B . (1998). _Annu. Rev. Biochem._, 67, 721–751. * Warbrick E, Coates PJ and


Hall PA . (1998). _J. Pathol._, 186, 319–324. * Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, Meijers Heijboer H, Lindhout D, Moller P and Fodde R . (1998). _Nat. Genet._,


20, 326–328. * Wistuba, Bryant D, Behrens C, Milchgrub S, Virmani AK, Ashfaq R, Minna JD and Gazdar AF . (1999). _Clin. Cancer Res._, 5, 991–1000. * Yan H, Papadopoulos N, Marra G, Perrera


C, Jiricny J, Boland CR, Lynch HT, Chadwick RB, de la Chapelle A, Berg K, Eshleman JR, Yuan W, Markowitz S, Laken SJ, Lengauer C, Kinzler KW and Vogelstein B . (2000). _Nature_, 403,


723–724. * Zochbauer-Muller S, Gazdar AF and Minna JD . (2002). _Annu. Rev. Physiol._, 64, 681–708. Download references ACKNOWLEDGEMENTS This work was supported by Lung Cancer SPORE


P50CA70907, and the Gillson Longenbaugh Foundation. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Internal Medicine, Hamon Center for Therapeutic Oncology Research, University


of Texas Southwestern Medical Center, Dallas, 75390-8593, TX, USA Mitsuo Sato, Luc Girard, Ikuo Sekine, Noriaki Sunaga, Ruben D Ramirez, Craig Kamibayashi & John D Minna * Department of


Pharmacology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, 75390-8593, TX, USA Mitsuo Sato, Luc Girard, Ikuo Sekine, Noriaki


Sunaga, Ruben D Ramirez, Craig Kamibayashi & John D Minna Authors * Mitsuo Sato View author publications You can also search for this author inPubMed Google Scholar * Luc Girard View


author publications You can also search for this author inPubMed Google Scholar * Ikuo Sekine View author publications You can also search for this author inPubMed Google Scholar * Noriaki


Sunaga View author publications You can also search for this author inPubMed Google Scholar * Ruben D Ramirez View author publications You can also search for this author inPubMed Google


Scholar * Craig Kamibayashi View author publications You can also search for this author inPubMed Google Scholar * John D Minna View author publications You can also search for this author


inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to John D Minna. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Sato, M., Girard, L.,


Sekine, I. _et al._ Increased expression and no mutation of the _Flap endonuclease_ (_FEN1_) gene in human lung cancer. _Oncogene_ 22, 7243–7246 (2003).


https://doi.org/10.1038/sj.onc.1206977 Download citation * Received: 24 March 2003 * Revised: 25 June 2003 * Accepted: 26 June 2003 * Published: 16 October 2003 * Issue Date: 16 October 2003


* DOI: https://doi.org/10.1038/sj.onc.1206977 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is


not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * _Flap endonuclease 1_ (_FEN1_) * base excision


repair * microsatellite instability * lung cancer


Trending News

It’s a game, not war: twitter reacts to amit shah’s ‘strike’ post

After India defeated Pakistan on Sunday, 16 June, by 89 runs (DLS method) in a rain-interrupted ICC World Cup 2019 clash...

[withdrawn] near miss with a track worker at llandegai tunnel

News story NEAR MISS WITH A TRACK WORKER AT LLANDEGAI TUNNEL Near miss with a track worker at Llandegai tunnel, Gwynedd,...

Tom arnold shares arnold schwarzenegger’s advice

IS THERE ONE LESSON YOUR FATHER TAUGHT YOU THAT YOU WANT TO IMPART TO YOUR KIDS? I knew early on that if I wanted anythi...

Breaking down the twisty ending of netflix's dark comedy thriller 'sirens'

W_ARNING: THIS POST CONTAINS SPOILERS FOR _SIRENS_._ It's hard to imagine the delivery of an edible arrangement has...

Brain Health Action – Get to a Brain Healthy Workplace

HKS   Learn | Get to a Brain-Healthy Workplace Read this report from HKS about the role of place, process/policy, and te...

Latests News

Increased expression and no mutation of the flap endonuclease (fen1) gene in human lung cancer

ABSTRACT The underlying molecular mechanisms leading to microsatellite alteration and mutations in human lung cancer rem...

I get paid to be a tree house architect

Roderick Romero's day generally involves being suspended 30-plus feet off the ground. "It all started when I w...

Biphasic janus particles with nanoscale anisotropy

ABSTRACT Advances in the field of nanotechnology have fuelled the vision of future devices spawned from tiny functional ...

The little-known science that improved everything around us

UNESCO has declared 2014 as the International Year of Crystallography. But why? Quite simply because the science of crys...

Ssa warns of social security phishing scam

Memorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4  G...

Top